natgillin/translations-raw huggingface dataset:
It appears from the evaluations that biocidal products used as insecticides, acaricides and products to control other arthropods and containing abamectin may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Presoje so pokazale, da je za biocidne pripravke, ki se uporabljajo kot insekticidi, akaricidi in pripravki za nadzor drugih členonožcev ter vsebujejo abamektin, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include abamectin in Annex I to that Directive.
Zato je primerno vključiti abamektin v Prilogo I k navedeni direktivi.
It is therefore appropriate that Member States assess those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment and, when granting product authorisations, ensure that appropriate measures are taken or specific conditions imposed in order to reduce the identified risks to acceptable levels.
Zato je primerno, da države članice ocenijo scenarije uporabe ali izpostavljenosti ter tista tveganja za človeške populacije in okoljske predele, ki niso bila reprezentativno obravnavana v oceni tveganja na ravni Unije, ter da pri izdaji dovoljenj za pripravke zagotovijo, da se sprejmejo ustrezni ukrepi ali naložijo posebni pogoji za zmanjšanje ugotovljenih tveganj na sprejemljivo raven.
In the light of the risks identified for sediment when products are used with a certain application rate and emitted to a sewage treatment plant, it is appropriate to require that products are not authorised for such uses, unless data are submitted demonstrating that the product will meet the requirements of both Article 5 of and Annex VI to Directive 98/8/EC, if necessary by the application of appropriate risk mitigation measures.
Glede na tveganja, ugotovljena za usedline, kadar se pripravki uporabljajo v določenem odmerku in se oddajajo v napravo za obdelavo odpadne vode, je primerno zahtevati, da se ne dovoli taka uporaba pripravkov, razen če se predložijo podatki, ki kažejo, da bo pripravek izpolnjeval zahteve člena 5 Direktive 98/8/ES in Priloge VI k navedeni direktivi, po potrebi ob uporabi ustreznih ukrepov za zmanjševanje tveganja.
In particular, in the light of the possible risks for infants and children, appropriate risk mitigation measures should be taken to minimise the potential exposure of infants and children.
Zlasti bi bilo glede na možna tveganja za dojenčke in otroke treba izvesti tiste ustrezne ukrepe za zmanjševanje tveganja, s katerimi se kar najbolj zmanjša potencialna izpostavljenost dojenčkov in otrok.
It is important that the provisions of this Directive be applied simultaneously in all Member States in order to ensure equal treatment of biocidal products on the market containing the active substance abamectin and also to facilitate the proper operation of the biocidal products market in general.
Pomembno je, da se določbe te direktive uporabljajo hkrati v vseh državah članicah, da bi bilo tako zagotovljeno enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov abamektin, na trgu in tudi omogočeno ustrezno delovanje trga biocidnih pripravkov na splošno.
A reasonable period should be allowed to elapse before an active substance is included in Annex I to Directive 98/8/EC in order to permit Member States and interested parties to prepare themselves to meet the new requirements entailed and to ensure that applicants who have prepared dossiers can benefit fully from the 10-year period of data protection, which, in accordance with Article 12(1)(c)(ii) of Directive 98/8/EC, starts from the date of inclusion.
Pred vključitvijo aktivne snovi v Prilogo I k Direktivi 98/8/ES je treba zagotoviti ustrezno obdobje, ki bo državam članicam in zainteresiranim stranem omogočilo, da se pripravijo na izpolnjevanje novih zahtev, prijaviteljem, ki so pripravili dokumentacijo, pa, da lahko povsem izkoristijo desetletno obdobje za varstvo podatkov, ki se v skladu s členom 12(1)(c)(ii) Direktive 98/8/ES začne z dnem vključitve.
After inclusion, Member States should be allowed a reasonable period to implement Article 16(3) of Directive 98/8/EC.
Po vključitvi bi morale države članice imeti na voljo razumno dolgo obdobje za izvedbo člena 16(3) Direktive 98/8/ES.
Directive 98/8/EC should therefore be amended accordingly.
Direktivo 98/8/ES bi bilo treba zato ustrezno spremeniti.
Member States shall adopt and publish, by 30 June 2012 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice najpozneje do 30. junija 2012 sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo.
They shall apply those provisions from 1 July 2013.
Navedene predpise uporabljajo od 1. julija 2013.
Abamectin is a mixture of avermectin B1a and avermectin B1b
Abamektin je zmes avermektina B1a in avermektina B1b
IUPAC name: n.a.
Ime po IUPAC: ni podatkov
CAS No: 71751-41-2
Št. CAS: 71751-41-2
Avermectin B1a:
Avermektin B1a:
IUPAC name: (10E,14E,16E,22Z)-(1R,4S,5'S,6S,6'R,8R,12S,13S,20R,21R,24S)-6'-[(S)-secbutyl]-21,24-dihydroxy-5',11,13,22-tetramethyl-2-oxo-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6-spiro-2'-(5',6'-dihydro-2'H-pyran)-12-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabinohexopyranoside
Ime po IUPAC: (10E,14E,16E,22Z)-(1R,4S,5'S,6S,6'R,8R,12S,13S,20R,21R,24S)-6'-[(S)-sekbutil]-21,24-dihidroksi-5',11,13,22-tetrametil-2-okso-3,7,19-trioksatetraciklo[15.6.1.14,8.020,24]pentakoza-10,14,16,22-tetraen-6-spiro-2'-(5',6'-dihidro-2'H-piran)-12-il 2,6-dideoksi-4-O-(2,6-dideoksi-3-O-metil-α-L-arabino-heksopiranozil)-3-O-metil-α-L-arabinoheksopiranozid
EC No: 265-610-3
Št. ES: 265-610-3
CAS No: 65195-55-3
Št. CAS: 65195-55-3
IUPAC name: (10E,14E,16E,22Z)-(1R,4S,5'S,6S,6'R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-6'-isopropyl-5',11,13,22-tetramethyl-2-oxo-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6-spiro-2'-(5',6'-dihydro-2'H-pyran)-12-yl2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabinohexopyranoside
Ime po IUPAC: (10E,14E,16E,22Z)-(1R,4S,5'S,6S,6'R,8R,12S,13S,20R,21R,24S)-21,24-dihidroksi-6'-izopropil-5',11,13,22-tetrametil-2-okso-3,7,19-trioksatetraciklo[15.6.1.14,8.020,24]pentakoza-10,14,16,22-tetraen-6-spiro-2'-(5',6'-dihidro-2'H-piran)-12-il2,6-dideoksi-4-O-(2,6-dideoksi-3-O-metil-α-L-arabino-heksopiranozil)-3-O-metil-α-L-arabinoheksopiranozid
EC No: 265-611-9
Št. ES: 265-611-9
CAS No: 65195-56-4
Št. CAS: 65195-56-4
The active substance shall comply with all the following purities:
Aktivna snov mora biti v skladu z vsemi naslednjimi ravnmi čistosti:
minimum 900 g/kg
najmanj 900 g/kg;
minimum 830 g/kg
najmanj 830 g/kg;
maximum 80 g/kg
največ 80 g/kg
1 July 2013
1. julij 2013
When assessing the application for authorisation of a product in accordance with Article 5 and Annex VI, Member States shall assess, when relevant for the particular product, those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment.
Kadar je za določen pripravek to potrebno, države članice pri ocenjevanju vloge za izdajo dovoljenja za pripravek v skladu s členom 5 in Prilogo VI ocenijo scenarije uporabe ali izpostavljenosti ter tveganja za človeške populacije in okoljske predele, ki niso bila reprezentativno obravnavana v oceni tveganja na ravni Unije.
Products applied in such a way that emission to a sewage treatment plant cannot be prevented shall not be authorised for those application rates for which the Union level risk assessment showed unacceptable risks, unless data are submitted demonstrating that the product will meet the requirements of Article 5 and Annex VI, if necessary by the application of appropriate risk mitigation measures.
Tisti pripravki, ki se uporabljajo na tak način, da ni mogoče preprečiti oddajanja v napravo za obdelavo odpadne vode, se ne dovolijo za tiste odmerke, za katere je ocena tveganja na ravni Unije pokazala nesprejemljiva tveganja, razen če se predložijo podatki, ki kažejo, da bo pripravek izpolnjeval zahteve člena 5 in Priloge VI, po potrebi ob uporabi ustreznih ukrepov za zmanjševanje tveganja.
In particular, appropriate risk mitigation measures shall be taken to minimise the potential exposure of infants and children.’
Zlasti je treba izvesti tiste ustrezne ukrepe za zmanjševanje tveganja, s katerimi se kar najbolj zmanjša potencialna izpostavljenost dojenčkov in otrok.“
Commission Implementing Directive 2011/68/EU
Izvedbena direktiva Komisije 2011/68/EU
Commission Directives 2003/90/EC [3] and 2003/91/EC [4] were adopted to ensure that the varieties the Member States include in their national catalogues comply with the guidelines established by the Community Plant Variety Office (CPVO) as regards the characteristics to be covered as a minimum by the examination of the various species and the minimum conditions for examining the varieties, as far as such guidelines had been established.
Direktivi Komisije 2003/90/ES [3] in 2003/91/ES [4] sta bili sprejeti za zagotovitev, da sorte iz nacionalnih katalogov držav članic izpolnjujejo smernice, ki jih je določil Urad Skupnosti za rastlinske sorte (USRS) glede lastnosti, ki morajo biti zajete kot minimum pri preskušanju različnih vrst, in minimalnih pogojev za preskušanje sort, če so bile takšne smernice oblikovane.
The CPVO has since established further guidelines for one other species, and has updated existing ones.
USRS je od takrat določil nadaljnje smernice za drugo vrsto ali posodobil že obstoječe.
Annexes I and II to Directive 2003/90/EC are replaced by the text in Part A of the Annex to this Directive.
Prilogi I in II k Direktivi 2003/90/ES se nadomestita z besedilom iz dela A Priloge k tej direktivi.
The Annexes to Directive 2003/91/EC are replaced by the text in Part B of the Annex to this Directive.
Prilogi k Direktivi 2003/91/ES se nadomestita z besedilom iz dela B Priloge k tej direktivi.
For examinations started before 1 January 2012 Member States may apply Directives 2003/90/EC and 2003/91/EC in the version applying before their amendment by this Directive.
Za preskušanja, ki se začnejo pred 1. januarjem 2012, države članice lahko uporabljajo direktivi 2003/90/ES in 2003/91/ES v različicah, ki sta se uporabljali, preden sta bili spremenjeni s to direktivo.
Member States shall adopt and publish, by 31 December 2011 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice najpozneje do 31. decembra 2011 sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo.
They shall apply those provisions from 1 January 2012.
Navedene predpise uporabljajo od 1. januarja 2012.
TP 121/2 rev. 1 of 16.2.2011
TP 121/2 rev. 1 z dne 16.2.2011
TP 3/4 rev. 2 of 16.2.2011
TP 3/4 rev. 2 z dne 16.2.2011
Hybrids resulting from the crossing of a species of the genus Festuca with a species of the genus Lolium
hibridi, ki izhajajo iz križanja vrst iz rodu Festuca z vrstami iz rodu Lolium
TG/243/1 of 9.4.2008
TG/243/1 z dne 9.4.2008
TP 130/2 of 16.2.2011
TP 130/2 z dne 16.2.2011
TP 90/1 of 16.2.2011
TP 90/1 z dne 16.2.2011
TP 48/3 of 16.2.2011
TP 48/3 z dne 16.2.2011
TP 13/5 of 16.2.2011
TP 13/5 z dne 16.2.2011
Citrullus lanatus (Thumb.) Matsum. et Nakai
Citrullus lanatus (Thunb.) Matsum. et Nakai
Agrostis gigantea Roth.
Agrostis gigantea Roth
Agrostis capillaris L.
Agrostis capilaris L.
Commission Directive 2011/69/EU
Direktiva Komisije 2011/69/EU
amending Directive 98/8/EC of the European Parliament and of the Council to include imidacloprid as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev imidakloprida kot aktivne snovi v Prilogo I k Direktivi
That list includes imidacloprid.
Navedeni seznam vključuje imidakloprid.
Pursuant to Regulation (EC) No 1451/2007, imidacloprid has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that Directive.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja imidakloprida glede uporabe v 18. vrsti izdelkov, insekticidih, akaricidih in pripravkih za nadzor drugih členonožcev, kot je opredeljena v Prilogi V k navedeni direktivi.
Germany was designated as rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 15 September 2008 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Nemčija, ki je bila imenovana za državo članico poročevalko, je 15. septembra 2008 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
It appears from the evaluations that biocidal products used as insecticides, acaricides and products to control other arthropods and containing imidacloprid may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Ocene so pokazale, da je za biocidne pripravke, ki se uporabljajo kot insekticidi, akaricidi in pripravki za nadzor drugih členonožcev ter vsebujejo imidakloprid, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include imidacloprid in Annex I to that Directive.
Zato je primerno vključiti imidakloprid v Prilogo I k navedeni direktivi.
It is therefore appropriate that Member States assess those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment and, when granting product authorisations, ensure that appropriate measures are taken or specific conditions imposed in order to reduce the identified risks to acceptable levels.
Zato je primerno, da države članice ocenijo možnosti uporabe oziroma scenarije izpostavljenosti ter tveganja za prebivalce in okolje, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Unije, ter da pri izdaji dovoljenj za pripravke zagotovijo, da se sprejmejo ustrezni ukrepi ali naložijo posebni pogoji za zmanjšanje ugotovljenih tveganj na sprejemljivo raven.
In view of the risks identified for the aquatic compartment, it is appropriate to require that products are not authorised for uses in animal housings where emission to a sewage treatment plant or direct emission to surface water cannot be prevented, unless data is submitted demonstrating that the product will meet the requirements of both Article 5 of and Annex VI to Directive 98/8/EC, if necessary by the application of appropriate risk mitigation measures.
Zaradi ugotovljenega tveganja za vodne ekosisteme je primerno, da se zahteva, da se pripravkov ne sme uporabljati za objekte za namestitev živali, kjer se izpustov v napravo za čiščenje odplak ali neposrednih izpustov v površinske vode ne da preprečiti, razen če se predložijo podatki, ki dokazujejo, da bo pripravek izpolnjeval zahteve iz člena 5 Direktive 98/8/ES in Priloge VI k navedeni direktivi, če je potrebno z izvajanjem ustreznih ukrepov za zmanjševanje tveganja.
In particular, in the light of the possible risk for non-professionals, appropriate risk mitigation measures should be taken to minimise the potential exposure of infants and children.
Zlasti se zaradi možnega tveganja za nepoklicne uporabnike sprejmejo primerni ukrepi za zmanjšanje tveganja, s katerimi se zmanjša morebitna izpostavitev dojenčkov in otrok.
In the light of the findings relating to possible indirect human exposure via consumption of food, it is appropriate to require, where relevant, verification of the need to set new or amended existing maximum residue levels (MRLs) according to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council [3] or Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC [4].
Na podlagi izsledkov, povezanih z možno posredno izpostavljenostjo ljudi prek uživanja hrane, je po potrebi primerno zahtevati, da se preveri potreba po določitvi novih ali spremembi obstoječih zgornjih mejnih vrednosti ostankov (MRLs – maximum residue levels) v skladu z Uredbo (ES) št. 470/2009 Evropskega parlamenta in Sveta z dne 6. maja 2009 o določitvi postopkov Skupnosti za določitev mejnih vrednosti ostankov farmakološko aktivnih snovi v živilih živalskega izvora in razveljavitvi Uredbe Sveta (EGS) št. 2377/90 in spremembi Direktive 2001/82/ES Evropskega parlamenta in Sveta ter Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta [3] ali Uredbo Evropskega parlamenta in Sveta (ES) št. 396/2005 z dne 23. februarja 2005 o mejnih vrednostih ostankov pesticidov v ali na hrani in krmi rastlinskega in živalskega izvora ter o spremembi Direktive Sveta 91/414/EGS [4].
Measures should be adopted ensuring that the applicable MRLs are not exceeded.
Sprejmejo se ukrepi za zagotovitev, da se veljavne MRLs ne presežejo.
It is important that the provisions of this Directive be applied simultaneously in all Member States in order to ensure equal treatment of biocidal products on the market containing the active substance imidacloprid and also to facilitate the proper operation of the biocidal products market in general.
Pomembno je, da se določbe te direktive uporabljajo hkrati v vseh državah članicah, da bi bilo tako zagotovljeno enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov imidakloprid, na trgu in omogočeno ustrezno delovanje trga biocidnih pripravkov na splošno.
EC No: 428-040-8
Št. ES: 428-040-8
CAS No: 138261-41-3
Št. CAS: 138261-41-3
When assessing the application for authorisation of a product in accordance with Article 5 and Annex VI, Member States shall assess, when relevant for the particular product, those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment.
Kadar je za določen pripravek to potrebno, države članice pri ocenjevanju vloge za izdajo dovoljenja za pripravek v skladu s členom 5 in Prilogo VI ocenijo možnosti uporabe ali scenarije izpostavljenosti ter tveganja za prebivalce in okolje, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Unije.
Products shall not be authorised for uses in animal housings where emission to a sewage treatment plant or direct emission to surface water cannot be prevented, unless data is submitted demonstrating that the product will meet the requirements of Article 5 and Annex VI, if necessary by the application of appropriate risk mitigation measures.
Pripravki se ne smejo uporabljati za objekte za namestitev živali, kjer se izpustov v napravo za čiščenje odplak ali neposrednih izpustov v površinske vode ne da preprečiti, razen če se predložijo podatki, ki dokazujejo, da bo pripravek izpolnjeval zahteve iz člena 5 in Priloge VI, če je potrebno z izvajanjem ustreznih ukrepov za zmanjševanje tveganja.
In particular, appropriate risk mitigation measures shall be taken to minimise the potential exposure of infants and children.
Zlasti se sprejmejo primerni ukrepi za zmanjšanje tveganja, s katerimi se zmanjša morebitna izpostavitev dojenčkov in otrok.
For products containing imidacloprid that may lead to residues in food or feed, Member States shall verify the need to set new or amended existing maximum residue levels (MRLs) according to Regulation (EC) No 470/2009 or Regulation (EC) No 396/2005, and take any appropriate risk mitigation measures ensuring that the applicable MRLs are not exceeded.’
Za pripravke, ki vsebujejo imidakloprid in lahko puščajo ostanke v živilih ali krmi, morajo države članice preveriti potrebo po določitvi novih najvišjih mejnih vrednosti ostankov ali spremembi že obstoječih vrednosti v skladu z Uredbo (ES) št. 470/2009 ali Uredbo (ES) št. 396/2005 in sprejeti kakršne koli primerne ukrepe za zmanjšanje tveganja, s čimer se zagotovi, da veljavne najvišje mejne vrednosti niso presežene.“
Council Directive 2011/70/Euratom
Direktiva Sveta 2011/70/Euratom
establishing a Community framework for the responsible and safe management of spent fuel and radioactive waste
o vzpostavitvi okvira Skupnosti za odgovorno in varno ravnanje z izrabljenim gorivom in radioaktivnimi odpadki
Having regard to the Treaty establishing the European Atomic Energy Community, and in particular Articles 31 and 32 thereof,
ob upoštevanju Pogodbe o ustanovitvi Evropske skupnosti za atomsko energijo, zlasti členov 31 in 32 Pogodbe,
Having regard to the proposal from the European Commission, drawn up after obtaining the opinion of a group of persons appointed by the Scientific and Technical Committee from among scientific experts in the Member States,
ob upoštevanju predloga Evropske komisije, pripravljenega na podlagi mnenja skupine oseb, ki jih je izmed znanstvenih strokovnjakov iz držav članic imenoval Znanstveno-tehnični odbor,
Article 2(b) of the Treaty establishing the European Atomic Energy Community (‘Euratom Treaty’) provides for the establishment of uniform safety standards to protect the health of workers and of the general public.
V členu 2(b) Pogodbe o ustanovitvi Evropske skupnosti za atomsko energijo (v nadaljnjem besedilu: Pogodba Euratom) je določena postavitev enotnih varnostnih standardov za varovanje zdravja delavcev in prebivalstva.
Article 30 of the Euratom Treaty provides for the establishment of basic standards for the protection of the health of workers and the general public against the dangers arising from ionising radiations.
V členu 30 Pogodbe Euratom je določena opredelitev temeljnih standardov za varovanje zdravja delavcev in prebivalstva pred nevarnostmi, ki izvirajo iz ionizirajočih sevanj.
Article 37 of the Euratom Treaty requires Member States to provide the Commission with general data relating to any plan for the disposal of radioactive waste.
V členu 37 Pogodbe Euratom se od držav članic zahteva, da morajo Komisiji predložiti splošne podatke o vsakem načrtu za odlaganje radioaktivnih odpadnih snovi.
Council Directive 96/29/Euratom [3] establishes basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionising radiation.
Direktiva Sveta 96/29/Euratom [3] določa temeljne varnostne standarde za varstvo zdravja delavcev in prebivalstva pred nevarnostmi zaradi ionizirajočega sevanja.
That Directive has been supplemented by more specific legislation.
Navedena direktiva je bila dopolnjena z bolj specifično zakonodajo.
As recognised by the Court of Justice of the European Union in its case-law, the provisions of Chapter 3 of the Euratom Treaty, on health and safety, form a coherent whole conferring upon the Commission powers of some considerable scope in order to protect the population and the environment against the risks of nuclear contamination [4].
Kot v svoji sodni praksi ugotavlja Sodišče Evropske unije, določbe o zdravju in varnosti iz Poglavja 3 Pogodbe Euratom tvorijo skladno celoto in Komisiji podeljujejo precej široke pristojnosti za zaščito prebivalstva in okolja pred tveganji jedrske kontaminacije [4].